Last 12 months
Inside the activity.
0 purchase rows · 93 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 16 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 49 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 12, 2022 Filed Apr 14, 2022 20:35 UTC |
Lee YuchunDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $81.54 | $0.00 |
DisclosureSEC source: 0000899243-22-014804 · doc4.xml · derivative · entry 15 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 2,000 shares Expires 2023-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F14 · derivative.exercise_date: Fully vested. Read SEC document |
| April 12, 2022 Filed Apr 14, 2022 20:35 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 300 | $283.15 | $84,945.00 |
DisclosureSEC source: 0000899243-22-014804 · doc4.xml · nonDerivative · entry 5 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,875 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $283.15 (range $282.73 to $283.57). Read SEC document |
| April 12, 2022 Filed Apr 14, 2022 20:35 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 318 | $281.70 | $89,580.60 |
DisclosureSEC source: 0000899243-22-014804 · doc4.xml · nonDerivative · entry 4 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,175 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $281.70 (range $281.45 to $281.98). Read SEC document |
| April 12, 2022 Filed Apr 14, 2022 20:35 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 1,182 | $280.61 | $331,681.02 |
DisclosureSEC source: 0000899243-22-014804 · doc4.xml · nonDerivative · entry 3 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,493 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $280.61 (range $280.24 to $281.19). Read SEC document |
| April 12, 2022 Filed Apr 14, 2022 20:35 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 200 | $279.22 | $55,844.00 |
DisclosureSEC source: 0000899243-22-014804 · doc4.xml · nonDerivative · entry 2 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,675 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F3 · price: Open market sales reported on this line occurred at a weighted average price of $279.22 (range $279.14 to $279.30). Read SEC document |
| April 12, 2022 Filed Apr 14, 2022 20:35 UTC |
Lee YuchunDirector
|
Exercise / conversionCommon Stock | 2,000 | $81.54 | $163,080.00 |
DisclosureSEC source: 0000899243-22-014804 · doc4.xml · nonDerivative · entry 1 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,875 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 11, 2022 Filed Apr 12, 2022 20:07 UTC |
Lee YuchunDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $81.54 | $0.00 |
DisclosureSEC source: 0000899243-22-014551 · doc4.xml · derivative · entry 11 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 2,000 shares Expires 2023-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: Fully vested. Read SEC document |
| April 11, 2022 Filed Apr 12, 2022 20:07 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 110 | $281.58 | $30,973.80 |
DisclosureSEC source: 0000899243-22-014551 · doc4.xml · nonDerivative · entry 9 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,875 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F9 · price: Open market sales reported on this line occurred at a weighted average price of $281.58 (range $281.55 to $281.58). Read SEC document |
| April 11, 2022 Filed Apr 12, 2022 20:07 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 968 | $280.62 | $271,640.16 |
DisclosureSEC source: 0000899243-22-014551 · doc4.xml · nonDerivative · entry 8 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,985 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F8 · price: Open market sales reported on this line occurred at a weighted average price of $280.62 (range $280.31 to $281.28). Read SEC document |
| April 11, 2022 Filed Apr 12, 2022 20:07 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 922 | $279.81 | $257,984.82 |
DisclosureSEC source: 0000899243-22-014551 · doc4.xml · nonDerivative · entry 7 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,953 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F7 · price: Open market sales reported on this line occurred at a weighted average price of $279.81 (range $279.29 to $280.18). Read SEC document |
| April 11, 2022 Filed Apr 12, 2022 20:07 UTC |
Lee YuchunDirector
|
Exercise / conversionCommon Stock | 2,000 | $81.54 | $163,080.00 |
DisclosureSEC source: 0000899243-22-014551 · doc4.xml · nonDerivative · entry 6 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,875 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 08, 2022 Filed Apr 12, 2022 20:05 UTC |
MCGLYNN MARGARET GDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $127.54 | $0.00 |
DisclosureSEC source: 0000899243-22-014548 · doc4.xml · derivative · entry 4 MCGLYNN MARGARET G · CIK 0001215126 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2025-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| April 08, 2022 Filed Apr 12, 2022 20:05 UTC |
MCGLYNN MARGARET GDirector
|
SaleCommon Stock | 100 | $281.49 | $28,149.00 |
DisclosureSEC source: 0000899243-22-014548 · doc4.xml · nonDerivative · entry 3 MCGLYNN MARGARET G · CIK 0001215126 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,099 F1 · kind: Transaction made pursuant to Ms. McGlynn's company approved trading plan under Rule 10b5-1. Read SEC document |
| April 08, 2022 Filed Apr 12, 2022 20:05 UTC |
MCGLYNN MARGARET GDirector
|
SaleCommon Stock | 4,900 | $280.19 | $1,372,931.00 |
DisclosureSEC source: 0000899243-22-014548 · doc4.xml · nonDerivative · entry 2 MCGLYNN MARGARET G · CIK 0001215126 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,199 F1 · kind: Transaction made pursuant to Ms. McGlynn's company approved trading plan under Rule 10b5-1. F2 · price: Ms. McGlynn undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F3 · price: Open market sales reported on this line occurred at a weighted average price of $280.19 (range $280.00 to $280.95). Read SEC document |
| April 08, 2022 Filed Apr 12, 2022 20:05 UTC |
MCGLYNN MARGARET GDirector
|
Exercise / conversionCommon Stock | 5,000 | $127.54 | $637,700.00 |
DisclosureSEC source: 0000899243-22-014548 · doc4.xml · nonDerivative · entry 1 MCGLYNN MARGARET G · CIK 0001215126 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,099 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 08, 2022 Filed Apr 12, 2022 20:05 UTC |
Bhatia Sangeeta N.Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,907 | $0.00 Strike: $125.71 | $0.00 |
DisclosureSEC source: 0000899243-22-014549 · doc4.xml · derivative · entry 3 Bhatia Sangeeta N. · CIK 0001643921 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,907 shares Expires 2027-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| April 08, 2022 Filed Apr 12, 2022 20:05 UTC |
Bhatia Sangeeta N.Director
|
SaleCommon Stock | 1,907 | $280.20 | $534,341.40 |
DisclosureSEC source: 0000899243-22-014549 · doc4.xml · nonDerivative · entry 2 Bhatia Sangeeta N. · CIK 0001643921 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,191 F1 · kind: Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1. F2 · price: Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F3 · price: Open market sales reported on this line occurred at a weighted average price of $280.20 (range $280.00 to $280.53). Read SEC document |
| April 08, 2022 Filed Apr 12, 2022 20:05 UTC |
Bhatia Sangeeta N.Director
|
Exercise / conversionCommon Stock | 1,907 | $125.71 | $239,728.97 |
DisclosureSEC source: 0000899243-22-014549 · doc4.xml · nonDerivative · entry 1 Bhatia Sangeeta N. · CIK 0001643921 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,098 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 08, 2022 Filed Apr 12, 2022 20:07 UTC |
Lee YuchunDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $81.54 | $0.00 |
DisclosureSEC source: 0000899243-22-014551 · doc4.xml · derivative · entry 10 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 2,000 shares Expires 2023-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: Fully vested. Read SEC document |
| April 08, 2022 Filed Apr 12, 2022 20:07 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 452 | $280.37 | $126,727.24 |
DisclosureSEC source: 0000899243-22-014551 · doc4.xml · nonDerivative · entry 5 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,875 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $280.37 (range $280.06 to $281.02). Read SEC document |
| April 08, 2022 Filed Apr 12, 2022 20:07 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 700 | $279.36 | $195,552.00 |
DisclosureSEC source: 0000899243-22-014551 · doc4.xml · nonDerivative · entry 4 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,327 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $279.36 (range $278.86 to $279.74). Read SEC document |
| April 08, 2022 Filed Apr 12, 2022 20:07 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 430 | $277.29 | $119,234.70 |
DisclosureSEC source: 0000899243-22-014551 · doc4.xml · nonDerivative · entry 3 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,027 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $277.29 (range $277.16 to $277.46). Read SEC document |
| April 08, 2022 Filed Apr 12, 2022 20:07 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 418 | $276.62 | $115,627.16 |
DisclosureSEC source: 0000899243-22-014551 · doc4.xml · nonDerivative · entry 2 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,457 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F3 · price: Open market sales reported on this line occurred at a weighted average price of $276.62 (range $276.08 to $276.81). Read SEC document |
| April 08, 2022 Filed Apr 12, 2022 20:07 UTC |
Lee YuchunDirector
|
Exercise / conversionCommon Stock | 2,000 | $81.54 | $163,080.00 |
DisclosureSEC source: 0000899243-22-014551 · doc4.xml · nonDerivative · entry 1 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,875 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 07, 2022 Filed Apr 8, 2022 20:34 UTC |
Sanna BastianoEVP, Cell & Genetic Therapies
|
SaleCommon Stock | 30 | $277.02 | $8,310.60 |
DisclosureSEC source: 0000899243-22-014360 · doc4.xml · nonDerivative · entry 3 Sanna Bastiano · CIK 0001829069 · EVP, Cell & Genetic Therapies 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,782 F1 · kind: Transaction made pursuant to Mr. Sanna's company approved trading plan under Rule 10b5-1. Read SEC document |
| April 07, 2022 Filed Apr 8, 2022 20:34 UTC |
Sanna BastianoEVP, Cell & Genetic Therapies
|
SaleCommon Stock | 327 | $276.39 | $90,379.53 |
DisclosureSEC source: 0000899243-22-014360 · doc4.xml · nonDerivative · entry 2 Sanna Bastiano · CIK 0001829069 · EVP, Cell & Genetic Therapies 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,812 F1 · kind: Transaction made pursuant to Mr. Sanna's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Sanna undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $276.39 (range $276.00 to $276.78). Read SEC document |
| April 07, 2022 Filed Apr 8, 2022 20:34 UTC |
Sanna BastianoEVP, Cell & Genetic Therapies
|
SaleCommon Stock | 204 | $275.71 | $56,244.84 |
DisclosureSEC source: 0000899243-22-014360 · doc4.xml · nonDerivative · entry 1 Sanna Bastiano · CIK 0001829069 · EVP, Cell & Genetic Therapies 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,139 F1 · kind: Transaction made pursuant to Mr. Sanna's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Sanna undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F3 · price: Open market sales reported on this line occurred at a weighted average price of $275.71 (range $275.00 to $275.95). Read SEC document |
| April 07, 2022 Filed Apr 8, 2022 21:57 UTC |
Lee YuchunDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $81.54 | $0.00 |
DisclosureSEC source: 0000899243-22-014367 · doc4.xml · derivative · entry 13 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 2,000 shares Expires 2023-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Fully vested. Read SEC document |
| April 07, 2022 Filed Apr 8, 2022 21:57 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 100 | $277.02 | $27,702.00 |
DisclosureSEC source: 0000899243-22-014367 · doc4.xml · nonDerivative · entry 11 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,875 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. Read SEC document |
| April 07, 2022 Filed Apr 8, 2022 21:57 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 727 | $276.37 | $200,920.99 |
DisclosureSEC source: 0000899243-22-014367 · doc4.xml · nonDerivative · entry 10 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,975 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F10 · price: Open market sales reported on this line occurred at a weighted average price of $276.37 (range $275.94 to $276.82). Read SEC document |
| April 07, 2022 Filed Apr 8, 2022 21:57 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 256 | $275.26 | $70,466.56 |
DisclosureSEC source: 0000899243-22-014367 · doc4.xml · nonDerivative · entry 9 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,702 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F9 · price: Open market sales reported on this line occurred at a weighted average price of $275.26 (range $274.64 to $275.43). Read SEC document |
| April 07, 2022 Filed Apr 8, 2022 21:57 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 500 | $273.78 | $136,890.00 |
DisclosureSEC source: 0000899243-22-014367 · doc4.xml · nonDerivative · entry 8 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,958 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F8 · price: Open market sales reported on this line occurred at a weighted average price of $273.78 (range $273.52 to $273.98). Read SEC document |
| April 07, 2022 Filed Apr 8, 2022 21:57 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 417 | $272.76 | $113,740.92 |
DisclosureSEC source: 0000899243-22-014367 · doc4.xml · nonDerivative · entry 7 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,458 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F7 · price: Open market sales reported on this line occurred at a weighted average price of $272.76 (range $272.50 to $273.28). Read SEC document |
| April 07, 2022 Filed Apr 8, 2022 21:57 UTC |
Lee YuchunDirector
|
Exercise / conversionCommon Stock | 2,000 | $81.54 | $163,080.00 |
DisclosureSEC source: 0000899243-22-014367 · doc4.xml · nonDerivative · entry 6 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,875 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 06, 2022 Filed Apr 8, 2022 21:57 UTC |
Lee YuchunDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $81.54 | $0.00 |
DisclosureSEC source: 0000899243-22-014367 · doc4.xml · derivative · entry 12 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 2,000 shares Expires 2023-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Fully vested. Read SEC document |
| April 06, 2022 Filed Apr 8, 2022 21:57 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 83 | $272.84 | $22,645.72 |
DisclosureSEC source: 0000899243-22-014367 · doc4.xml · nonDerivative · entry 5 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,875 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $272.84 (range $272.56 to $272.97). Read SEC document |
| April 06, 2022 Filed Apr 8, 2022 21:57 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 1,600 | $271.78 | $434,848.00 |
DisclosureSEC source: 0000899243-22-014367 · doc4.xml · nonDerivative · entry 4 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,958 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $271.78 (range $271.43 to $272.33). Read SEC document |
| April 06, 2022 Filed Apr 8, 2022 21:57 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 300 | $270.67 | $81,201.00 |
DisclosureSEC source: 0000899243-22-014367 · doc4.xml · nonDerivative · entry 3 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,558 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F3 · price: Open market sales reported on this line occurred at a weighted average price of $270.67 (range $270.42 to $270.88). Read SEC document |
| April 06, 2022 Filed Apr 8, 2022 21:57 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 17 | $267.57 | $4,548.69 |
DisclosureSEC source: 0000899243-22-014367 · doc4.xml · nonDerivative · entry 2 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,858 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. Read SEC document |
| April 06, 2022 Filed Apr 8, 2022 21:57 UTC |
Lee YuchunDirector
|
Exercise / conversionCommon Stock | 2,000 | $81.54 | $163,080.00 |
DisclosureSEC source: 0000899243-22-014367 · doc4.xml · nonDerivative · entry 1 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,875 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 05, 2022 Filed Apr 6, 2022 20:59 UTC |
Lee YuchunDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $81.54 Strike: $81.54 | $163,080.00 |
DisclosureSEC source: 0000899243-22-014117 · doc4.xml · derivative · entry 13 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 2,000 shares Expires 2023-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: Fully vested. Read SEC document |
| April 05, 2022 Filed Apr 6, 2022 20:59 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 461 | $274.66 | $126,618.26 |
DisclosureSEC source: 0000899243-22-014117 · doc4.xml · nonDerivative · entry 11 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,875 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F8 · price: Open market sales reported on this line occurred at a weighted average price of $274.66 (range $274.63 to $274.68). Read SEC document |
| April 05, 2022 Filed Apr 6, 2022 20:59 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 100 | $273.50 | $27,350.00 |
DisclosureSEC source: 0000899243-22-014117 · doc4.xml · nonDerivative · entry 10 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,336 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. Read SEC document |
| April 05, 2022 Filed Apr 6, 2022 20:59 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 600 | $272.60 | $163,560.00 |
DisclosureSEC source: 0000899243-22-014117 · doc4.xml · nonDerivative · entry 9 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,436 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F7 · price: Open market sales reported on this line occurred at a weighted average price of $272.60 (range $272.36 to $273.34). Read SEC document |
| April 05, 2022 Filed Apr 6, 2022 20:59 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 488 | $271.94 | $132,706.72 |
DisclosureSEC source: 0000899243-22-014117 · doc4.xml · nonDerivative · entry 8 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,036 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $271.94 (range $271.35 to $272.27). Read SEC document |
| April 05, 2022 Filed Apr 6, 2022 20:59 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 334 | $270.05 | $90,196.70 |
DisclosureSEC source: 0000899243-22-014117 · doc4.xml · nonDerivative · entry 7 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,524 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $270.05 (range $269.79 to $270.64). Read SEC document |
| April 05, 2022 Filed Apr 6, 2022 20:59 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 17 | $268.30 | $4,561.10 |
DisclosureSEC source: 0000899243-22-014117 · doc4.xml · nonDerivative · entry 6 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,858 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. Read SEC document |
| April 05, 2022 Filed Apr 6, 2022 20:59 UTC |
Lee YuchunDirector
|
Exercise / conversionCommon Stock | 2,000 | $81.54 | $163,080.00 |
DisclosureSEC source: 0000899243-22-014117 · doc4.xml · nonDerivative · entry 5 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,875 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 05, 2022 Filed Apr 6, 2022 21:02 UTC |
Sanna BastianoEVP, Cell & Genetic Therapies
|
SaleCommon Stock | 3,163 | $275.23 | $870,552.49 |
DisclosureSEC source: 0000899243-22-014120 · doc4.xml · nonDerivative · entry 3 Sanna Bastiano · CIK 0001829069 · EVP, Cell & Genetic Therapies 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,343 F1 · kind: Transaction made pursuant to Mr. Sanna's company approved trading plan under Rule 10b5-1. F2 · price: Mr. Sanna undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $275.23 (range $275.00 to $275.66). Read SEC document |
| April 04, 2022 Filed Apr 6, 2022 20:59 UTC |
Lee YuchunDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $81.54 Strike: $81.54 | $163,080.00 |
DisclosureSEC source: 0000899243-22-014117 · doc4.xml · derivative · entry 12 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 2,000 shares Expires 2023-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: Fully vested. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.